JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB303610

Anti-CD40 Ligand antibody [EPR26530-17]

Be the first to review this product! 리뷰 제출

|

(1 출판물)

Rabbit Recombinant Monoclonal TRAP/CD40L antibody. Suitable for IP, IHC-P, WB and reacts with Human samples. Cited in 1 publication.
6 이미지
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

Immunohistochemical analysis of paraffin-embedded (A) Wild-type Jurkat tissue labeling CD40 Ligand with ab303610 at 1/500 (1.062 ug/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Positive staining on wild-type Jurkat (human T cell leukemia T lymphocyte from peripheral blood) cell pellet (A) and Jurkat treated with 50ng/ml 48h PMA for 48h, then treated with 300ng/ml BFA and 3¦МM monensin for 24h cell pellet (B). No staining on wild-type Raji (human Burkitt's lymphoma B lymphocyte) cell pellet. The section was incubated with ab303610 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

Immunohistochemical analysis of paraffin-embedded Human tonsil tissue labeling CD40 Ligand with ab303610 at 1/500 (1.062 ug/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Positive staining on human tonsil (PMID : 7699321). The section was incubated with ab303610 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

Immunohistochemical analysis of paraffin-embedded Human skeletal muscle tissue labeling CD40 Ligand with ab303610 at 1/500 (1.062 ug/ml) followed by a ready to use LeicaDS9800 (Bond® Polymer Refine Detection). Negative control : No staining on human skeletal muscle (PMID : 1281209). The section was incubated with ab303610 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is a ready to use LeicaDS9800 (Bond® Polymer Refine Detection) was used. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins

Immunoprecipitation - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • IP

Supplier Data

Immunoprecipitation - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

CD40 Ligand was immunoprecipitated from 0.35 mg D1.1 (human T lymphoblast) whole cell lysate 10 ug with ab303610 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab303610 at 1/1000 dilution. VeriBlot for IP secondary antibody (HRP) (ab131366) was used at 1/5000 dilution.

Lane 1 : D1.1 (human T lymphoblast) whole cell lysate 10 ug
Lane 2 : ab303610 IP in D1.1 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab303610 in D1.1 whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 180 seconds

All lanes:

Immunoprecipitation - Anti-CD40 Ligand antibody [EPR26530-17] (ab303610) at 1/1000 dilution

Lane 1:

D1.1 (human T lymphoblast) whole cell lysate 10 μg

Lane 2:

D1.1 whole cell lysate

Secondary

All lanes:

Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/ko/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution

Observed band size: 17 kDa,25 kDa,30 kDa

false

Exposure time: 180s

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • WB

Supplier Data

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

Blocking and diluting buffer and concentration : 5% NFDM/TBSTNegative control : human skeletal muscle(PMID : 1281209) The antibody recognizes both membrane bound(25-30KDa) and soluble(17KDa) form. Exposure time : 180 seconds

All lanes:

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (ab303610) at 1/1000 dilution

Lane 1:

Human lymphma tissue lysate 50 μg

Lane 2:

Human spleen tissue lysate 50 μg

Lane 3:

Human tonsil tissue lysate 50 μg

Lane 4:

Human skeletal muscle tissue lysate 50 μg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/1000 dilution

Observed band size: 17 kDa,25 kDa,30 kDa

false

Exposure time: 180s

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)
  • WB

Supplier Data

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (AB303610)

Blocking and diluting buffer and concentration : 5% NFDM/TBSTNegative control : Raji(PMID : 12805559) The antibody recognizes both membrane bound(25-30KDa) and soluble(17KDa) form. Exposure time : 3.25 seconds

All lanes:

Western blot - Anti-CD40 Ligand antibody [EPR26530-17] (ab303610) at 1/1000 dilution

Lane 1:

Untreated Jurkat (human T cell leukemia T lymphocyte from peripheral blood), whole cell lysate 50 μg

Lane 2:

Jurkat treated with /ml 48h PMA for 48h, then treated with 300ng/ml BFA and 3uM monensin for 24h, whole cell lysate 50 μg

Lane 3:

D1.1 (human T lymphoblast), whole cell lysate 50 μg

Lane 4:

Raji (human Burkitts lymphoma B lymphocyte), whole cell lysate 50 μg

Secondary

All lanes:

Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/1000 dilution

Observed band size: 17 kDa,25 kDa,30 kDa

false

Exposure time: 3.25s

관련 conjugated 항체와 다양한 조성의 항체 (1)

  • Carrier free

    Anti-CD40 Ligand antibody [EPR26530-17] - BSA and Azide free

주요 정보

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR26530-17

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IP, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Rat": { "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/500", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

제품 세부 정보

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification Protein A
보관 버퍼
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
배송 시 보관 조건
Conditional Ambient
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle

제품 프로토콜

For this product, it's our understanding that no specific protocols are required. You can visit:

타겟 정보

Cytokine that acts as a ligand to CD40/TNFRSF5 (PubMed : 1280226, PubMed : 31331973). Costimulates T-cell proliferation and cytokine production (PubMed : 8617933). Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation (PubMed : 8617933). Induces the activation of NF-kappa-B (PubMed : 15067037, PubMed : 31331973). Induces the activation of kinases MAPK8 and PAK2 in T-cells (PubMed : 15067037). Induces tyrosine phosphorylation of isoform 3 of CD28 (PubMed : 15067037). Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity).. CD40 ligand, soluble form. Acts as a ligand for integrins, specifically ITGA5 : ITGB1 and ITGAV : ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling.
See full target information CD40LG

대체 명칭 보기

CD154, CD40L, TNFSF5, TRAP, CD40LG, CD40 ligand, CD40-L, T-cell antigen Gp39, TNF-related activation protein, Tumor necrosis factor ligand superfamily member 5

제품이 사용된 논문 (1)

Recent publications for all applications. Explore the 전체 목록 and refine your search

Clinical and molecular hepatology 31:935-959 PubMed39924997

2025

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target.

Applications

Unspecified application

Species

Unspecified reactive species

Gu-Wei Ji,Zheng-Gang Xu,Shuo-Chen Liu,Shu-Ya Cao,Chen-Yu Jiao,Ming Lu,Biao Zhang,Yue Yang,Qing Xu,Xiao-Feng Wu,Ke Wang,Yong-Xiang Xia,Xiang-Cheng Li,Xue-Hao Wang
제품이 사용된 논문 모두 보기

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com